Insecticides (India) Limited (IIL), one of India’s leading crop protection and nutrition company, has announced its financial results for the quarter and nine month ended December 31, 2024.

The company posted net profit of Rs. Rs. 17.4 crore in Q3 FY25 as compared to Rs. 12.3 croe in Q3 FY24, reflecting a growth of 42 per cent. Revenue from Operations during Q3 FY25 remained flat at Rs. 357.7 crore.

For the 9 months period ended December 31, 2024, Insecticides (India) posted a PQAT of Rs. 128.1 crore compared tp Rs. 94.6 crore, posing a growth of 36 per cent. 

Commenting on the results and performance, Rajesh Aggarwal, MD of Insecticides (India) Ltd. said: “We are excited to share our robust performance during current quarter with 42% growth in PAT. This is in line with the strategic framework established at start of the year focusing on profitable growth with higher share of Premium Products and improving its margins. The first nine months has been in line with expectations, driven by strong contributions from our premium product range, which now constitutes 62% of B2C revenue and significant improvements in our EBITDA margins.

We are optimistic about the upcoming seasons, supported by favorable tailwinds such as a strong monsoon, increased reservoir levels, and enhanced crop sowing. Furthermore, government policies in latest Union Budget for increasing farmer income and thrust on increasing output for cotton, pulses etc. are expected to provide additional positive momentum. We are delighted to share that we have received an overwhelming response from market to our new launches providing latest technology and complete crop solution to the farmers. Our commitment to innovation remains steadfast as we continue to enhance our technology offerings for farmers.

In Q2 FY25, we acquired Kaeros Research Private Limited aimed at securing supply chains and reducing costs through direct imports. Kaeros holds import licenses and vendor approvals, providing valuable benefits. The acquisition was executed at fair value and is accretive to shareholder value. The Company’s fully paid-up capital is Rs. 4.78 crores, with land assets situated in Shamli, Uttar Pradesh used for field trials.

We remain committed to investing in cutting-edge technology, fostering innovation, and ensuring operational excellence to deliver sustainable, profitable growth. With a clear vision and a solid foundation, we are confident in our ability to generate lasting value for our stakeholders and build a promising future for our business.”

Operational Highlights

• 10 new products launched in first nine months including patented latest technology products

• Launched Centran, a patented 9(3) insecticide with dual-action for paddy. It aims to boost productivity and support farmers' economic growth

• Torry Super an innovative 9(3) herbicide for maize which is based on SPF technology, developed by in-house R&D team

• Tie up with BioPrime to brings Relieve, it is exclusive biological product for the Indian market, furthering efforts to provide sustainable solutions for Indian agriculture.

• Received Patent for IZUKI, a fungicide for paddy. This has been developed in technical collaboration with Nissan Chemical Corporation Japan